Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. Baiyunshan Pharmaceutical General Factory currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner. The presence of this pending action indicates the current scale of the company's interaction with the patent office.
The busiest examiner is OTTON, ALICIA L, who is responsible for 1 pending office action. Because the portfolio involves 1 distinct art unit, the prosecution is currently handled within that specific technical group. This structure provides a direct point of contact for the company's pending patent application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OTTON, ALICIA L | 1 | 65.0% | +9.3% |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18714631 | NOVEL NON-FLUORINATED QUINOLONE COMPOUND AND USE THEREOF | OTTON, ALICIA L | 1699 | §112 | Non-Final OA | — | Pending | May 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. Baiyunshan Pharmaceutical General Factory has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alicia L Otton has the most, with 1 of Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. Baiyunshan Pharmaceutical General Factory's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
